These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11512190)

  • 21. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
    Koschinsky ML; Marcovina SM
    Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No association between the angiotensin-converting-enzyme gene insertion/deletion polymorphism and the occurrence of macroangiopathy in patients with diabetes mellitus type 2.
    Klemm T; Mittrach-Schorin S; Neumann S; Gerike T; Krankenberg H; Schuler G; Paschke R
    Horm Metab Res; 2003 Jan; 35(1):43-7. PubMed ID: 12669270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
    J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications.
    Gazzaruso C; Garzaniti A; Buscaglia P; D'Annunzio G; Porta A; Vandelli G; Lorini R; Finardi G; Fratino P; Geroldi D
    Acta Diabetol; 1998 Apr; 35(1):13-8. PubMed ID: 9625284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein A-I gene polymorphism and susceptibility of non-insulin-dependent diabetes mellitus.
    Buraczynska M; Hanzlik J; Grzywa M
    Am J Hum Genet; 1985 Nov; 37(6):1129-37. PubMed ID: 3936351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
    Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
    Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
    Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.
    Kahraman S; Kiykim AA; Altun B; Gençtoy G; Arici M; Gulsun M; Erdem Y; Yasavul U; Turgan C; Cağlar S
    Clin Transplant; 2004 Jun; 18(3):288-94. PubMed ID: 15142050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
    J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.
    Gazzaruso C; Bruno R; Pujia A; De Amici E; Fratino P; Solerte SB; Garzaniti A
    Int J Cardiol; 2006 Apr; 108(3):354-8. PubMed ID: 15961173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
    Lajer M; Tarnow L; Fleckner J; Hansen BV; Edwards DG; Parving HH; Boel E
    Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The atherogenic aspect of the lipoprotein composition in hemodialysis patients].
    Viener A; Aviram M; Brook JG
    Harefuah; 1986 Mar; 110(5):217-9. PubMed ID: 3087842
    [No Abstract]   [Full Text] [Related]  

  • 37. No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications.
    Rudofsky G; Schlimme M; Schlotterer A; von Eynatten M; Reismann P; Tafel J; Grafe I; Morcos M; Nawroth P; Bierhaus A; Hamann A
    Diabetes Obes Metab; 2005 Jul; 7(4):455-9. PubMed ID: 15955133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
    Hasegawa G; Obayashi H; Kamiuchi K; Nakai M; Kanatsuna T; Yamaguchi M; Tanaka T; Shigeta H; Fujii M; Yoshikawa T; Nakamura N
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemocoagulation changes in patients with type I diabetes mellitus in renal insufficiency].
    Charvát J; Neuwirtová K; König J; Spánková H; Mlejnková M; Jarosová H
    Cas Lek Cesk; 1985 Jul; 124(27):856-9. PubMed ID: 4016886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.